
Metvian G 1mg/500mg Tablet SR
Marketer
Vivichem Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Metvian G 1mg/500mg Tablet SR
Diabexe Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation can lead to elevated blood sugar, potentially resulting in kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.
Uses of Metvian G 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Metvian G 1mg/500mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Metvian G 1mg/500mg Extended-Release tablets with food.
Common Side effects of Metvian G 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Metvian G 1mg/500mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing. Consume the Metvian G 1mg/500mg sustained-release tablet with food.
How Metvian G 1mg/500mg Tablet SR works:
Metvian G 1mg/500mg Extended-Release Tablets combine glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Metvian G 1mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Metvian G 1mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Metvian G 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Impaired driving is possible with abnormally low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
For individuals with kidney impairment, Metvian G 1mg/500mg Tablet SR requires careful administration. Dosage modification of Metvian G 1mg/500mg Tablet SR may be necessary. Physician consultation is recommended. In cases of severe kidney disease, Metvian G 1mg/500mg Tablet SR is contraindicated. Routine monitoring of kidney function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Metvian G 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Metvian G 1mg/500mg Tablet SR is typically initiated at a reduced dosage; however, it's contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Metvian G 1mg/500mg Tablet SR :
Should you forget a Metvian G 1mg/500mg SR Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metvian G 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
